Riboprine
Riboprine is a small molecule pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| american red cross ipa 50% 6oz | C200263 | 2026-07-01 |
| c2020 ipa hand senitizer | OTC monograph not final | 2021-06-26 |
| compass 70% ethanol hand sanitizer gel with citrus compass 70% ethanol hand sanitizer gel with lavender dr lucid 70% ethanol hand sanitizer dr luci... | OTC monograph not final | 2022-08-24 |
| defense ag hand sanitizer | OTC monograph not final | 2020-09-25 |
| doctor inks ipa wipes | C200263 | 2026-05-04 |
| dr lucid 70% ethanol hand sanitizer dr lucid 70% ethanol hand sanitizer gel dr lucid 70% ipa sanitizer dr lucid 91% ipa sanitizer dr lucid hand san... | OTC monograph not final | 2020-10-01 |
| dr lucid 70% ipa sanitizer dr lucid 91% ipa sanitizer dr lucid hand sanitizer | OTC monograph not final | 2020-06-12 |
| dr lucid hand sanitizer | OTC monograph not final | 2020-05-28 |
| falcon hand sanitizer ipa based | OTC monograph not final | 2020-07-27 |
| hand sanitizer ipa gel hygenize hygenize hand sanitizer iris hand sanitizer gel | OTC monograph not final | 2020-10-03 |
Show 41 more
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
449 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Invasive pulmonary aspergillosis | D055744 | — | B44.0 | 1 | 3 | 1 | 3 | 25 | 33 |
| Inflammation | D007249 | MP_0001845 | — | — | 6 | 3 | 2 | 20 | 30 |
| Aspergillosis | D001228 | EFO_0007157 | B44 | 1 | 4 | 2 | 3 | 20 | 29 |
| Hypertriglyceridemia | D015228 | EFO_0004211 | — | 5 | 4 | 12 | 4 | 5 | 28 |
| Pulmonary aspergillosis | D055732 | EFO_1001834 | — | 1 | 3 | 1 | 3 | 17 | 25 |
| Healthy volunteers/patients | — | — | — | 6 | 1 | — | 1 | 15 | 23 |
| Cardiovascular diseases | D002318 | EFO_0000319 | I98 | 1 | 2 | 4 | 3 | 9 | 18 |
| Coronary artery disease | D003324 | — | I25.1 | — | 1 | 1 | 8 | 2 | 12 |
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | 1 | 1 | 3 | 2 | 5 | 12 |
| Obesity | D009765 | EFO_0001073 | E66.9 | — | 1 | — | 1 | 10 | 12 |
Show 67 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Depression | D003863 | — | F33.9 | 2 | 6 | 7 | — | 8 | 21 |
| Depressive disorder | D003866 | EFO_1002014 | F32.A | 2 | 2 | 5 | — | 8 | 16 |
| Major depressive disorder | D003865 | EFO_0003761 | F22 | 2 | 4 | 2 | — | 7 | 14 |
| Neoplasms | D009369 | — | C80 | 1 | 2 | 2 | — | 3 | 8 |
| Attention deficit disorder with hyperactivity | D001289 | EFO_0003888 | F90 | — | 1 | 2 | — | 5 | 8 |
| Surgical wound infection | D013530 | — | — | 2 | 2 | 2 | — | — | 6 |
| Insulin resistance | D007333 | EFO_0002614 | E88.819 | — | 1 | 1 | — | 4 | 6 |
| Hypertension | D006973 | EFO_0000537 | I10 | 1 | 1 | 1 | — | 4 | 6 |
| Cachexia | D002100 | — | R64 | — | — | 1 | — | 5 | 6 |
| Asthma | D001249 | EFO_0000270 | J45 | 1 | 1 | 1 | — | 2 | 5 |
Show 53 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 3 | 2 | — | — | 5 | 9 |
| Dyslipidemias | D050171 | — | — | 1 | 1 | — | — | 3 | 5 |
| Anxiety disorders | D001008 | EFO_0006788 | F41.1 | — | 3 | — | — | 2 | 5 |
| Leukemia | D007938 | — | C95 | — | 3 | — | — | 1 | 4 |
| Hematologic neoplasms | D019337 | — | — | — | 1 | — | — | 2 | 3 |
| Cognitive dysfunction | D060825 | — | G31.84 | — | 1 | — | — | 2 | 3 |
| Osteoarthritis | D010003 | EFO_0002506 | M15-M19 | — | 1 | — | — | 2 | 3 |
| Death | D003643 | PATO_0001422 | — | — | 1 | — | — | 2 | 3 |
| Myeloid leukemia | D007951 | — | C92 | — | 2 | — | — | 1 | 3 |
| Fatigue | D005221 | — | R53.83 | — | 1 | — | — | 2 | 3 |
Show 56 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Sarcopenia | D055948 | EFO_1000653 | M62.84 | 1 | — | — | — | 4 | 5 |
| Lipid metabolism disorders | D052439 | — | — | 2 | — | — | — | — | 2 |
| Nausea | D009325 | — | R11.0 | 1 | — | — | — | 1 | 2 |
| Emergencies | D004630 | — | — | 1 | — | — | — | 1 | 2 |
| Healthy diet | D000072001 | — | — | 2 | — | — | — | — | 2 |
| Breast carcinoma in situ | D000071960 | — | D05 | 1 | — | — | — | — | 1 |
| Vomiting | D014839 | — | R11.1 | 1 | — | — | — | — | 1 |
| Respiratory aspiration | D053120 | EFO_1001839 | — | 1 | — | — | — | — | 1 |
| Bariatric surgery | D050110 | — | — | 1 | — | — | — | — | 1 |
| Magnetic resonance imaging | D008279 | — | — | 1 | — | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Dry eye syndromes | D015352 | — | H04.12 | — | — | — | — | 7 | 7 |
| Keratoconjunctivitis sicca | D007638 | EFO_1000906 | — | — | — | — | — | 6 | 6 |
| Muscular atrophy | D009133 | — | — | — | — | — | — | 6 | 6 |
| Human influenza | D007251 | EFO_0007328 | J11.1 | — | — | — | — | 6 | 6 |
| Mycoses | D009181 | — | B35-B49 | — | — | — | — | 5 | 5 |
| Pneumonia | D011014 | EFO_0003106 | J18 | — | — | — | — | 5 | 5 |
| Pediatric obesity | D063766 | — | — | — | — | — | — | 4 | 4 |
| Peripheral nervous system diseases | D010523 | — | G64 | — | — | — | — | 3 | 3 |
| Rheumatoid arthritis | D001172 | EFO_0000685 | M06.9 | — | — | — | — | 3 | 3 |
| Metabolic syndrome | D024821 | EFO_0000195 | E88.810 | — | — | — | — | 3 | 3 |
Show 130 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Riboprine |
| INN | riboprine |
| Description | N(6)-(Delta(2)-isopentenyl)adenosine is a nucleoside analogue in which adenosine has been modified by substitution at the 6-amino nitrogen by a Delta(2)-isopentenyl group. It has a role as an antineoplastic agent, a plant growth regulator and a plant metabolite. It is a nucleoside analogue and a N-ribosyl-N(6)-isopentenyladenine. It is functionally related to an adenosine. |
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | CC(C)=CCNc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O |
Identifiers
| PDB | — |
| CAS-ID | 7724-76-7 |
| RxCUI | — |
| ChEMBL ID | CHEMBL452867 |
| ChEBI ID | 62881 |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | 8EU82FAZ5J (ChemIDplus, GSRS) |
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 9,999 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
202,507 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use